Market Cap (In GBp)
162.83 Million
Revenue (In GBp)
44.39 Billion
Net Income (In GBp)
5.82 Billion
Avg. Volume
163.27 Thousand
- Currency
- GBp
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 19.325-42.0
- PE
- -
- EPS
- -
- Beta Value
- 0.619
- ISIN
- US0885792061
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Mr. Mohammad Ali Nawaz
- Employee Count
- -
- Website
- https://www.beximcopharma.com
- Ipo Date
- 2005-10-21
- Details
- Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulation products and active pharmaceutical ingredients in Bangladesh. The company offers allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies. It provides its products in various dosage forms, including solid, liquid, cream and ointment, suppositories, metered dose and dry powder inhaler, nasal spray, sterile, lyophilized injectable, and large volume intravenous fluids. The company also exports its products. Beximco Pharmaceuticals Limited was incorporated in 1976 and is headquartered in Dhaka, Bangladesh.
More Stocks
-
601116
-
BPAQFBP p.l.c.
BPAQF
-
COSMCosmos Health Inc.
COSM
-
HWNI
-
6807FY Group Ltd.
6807
-
2208Bourbon Corporation
2208
-
FBK
-
VSSYWVersus Systems Inc.
VSSYW